Phase I of Lusure Pharma's APIs and preparations project: EI report to enter approval process

The environmental impact (EI) report of Phase I of "construction project for production of active pharmaceutical ingredients (API) and preparations" from Shandong Lusure Pharmaceutical Co., Ltd. (Lusure Pharma) was made public during the pre-submissi...

Vitamins China E-News 202401

www.cnchemicals.com